Research Psychiatrist, Center for Interdisciplinary Addiction Research at the University of Hamburg
Pro to the question "Should Marijuana Be a Medical Option?"
"While further research is required on the biological and clinical aspects of the benefits of cannabis use for HCV [hepatitis C] treatment, and the effectiveness of cannabis use for HCV treatment needs to be explored in larger study populations, we advocate that in the interim existing barriers to cannabis use are removed for drug users undergoing HCV treatment until the conclusive empirical basis for evidence-based guidance is available."
European Journal of Gastroenterology & Hepatology, Oct. 2006
Key Experts Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by sites that have this designation.]
Involvement and Affiliations:
Research Scientist, Psychiatric University Hospital, Hamburg, 2001-present
Research Scientist, Center for Interdisciplinary Addiction Research, University of Hamburg, 2001-present
Scientific Assistant, Neurology, der Ruhr-Universität Bochum, St. Josef Hospital, 2000-2001
Scientific Assistant, Department of Gastroenterologie and Hepatologie, Center for Inner Medicine, University of Essen, 1999-2000
Physician, Center for Inner Medicine, University of Essen, 1998-1999
Cowritten with Christian Haasen, Tomas Mueller-Thomsen, Torsten Fink, and Alexandra Bussopulos, "Zopiclone Dependence After Insomnia Related to Torticollis," The International Journal of Neuropsychopharmacology, 2005
Cowritten with Gabriele Helga Franke, Uwe Heemann, Mathias Kohnle, Peter Luetkes, and Nicole Maehner, "Quality of Life in Patients Before and After Kidney Transplanation," Psychology and Health